, 4,6-GalNAc? GalNAc?

?. Galnac?1 and . Oser,

, GalNAc?1?3(Fuc?1?2)Gal?1?4GlcNAc? (A type 2)

, Su)GalNAc?, vol.3

O. Blixt, S. Head, T. Mondala, C. Scanlan, M. E. Huflejt et al., Printed covalent glycan array for ligand profiling of diverse glycan binding proteins, Proc. Natl. Acad. Sci. U.S.A, vol.101, pp.17033-17038, 2004.

O. Blixt, E. Cló, A. S. Nudelman, K. K. Sørensen, T. Clausen et al., A high-throughput O-glycopeptide discovery platform for seromic profiling, J. Proteome Res, vol.9, issue.10, pp.5250-5261, 2010.

O. Blixt, D. Bueti, B. Burford, D. Allen, S. Julien et al., Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis, Breast Cancer Res, vol.13, issue.2, p.25, 2011.

O. Blixt, O. Lavrova, D. V. Mazurov, E. Clo, S. K. Kracun et al., Analysis of Tn-antigenicity with a panel of new IgM and IgG1 monoclonal antibodies raised against leukemic cells, Glycobiology, vol.22, pp.529-542, 2012.

N. V. Bovin, Natural antibodies to glycans, Biochemistry (Moscow), vol.78, pp.786-797, 2013.

N. V. Bovin, E. Korchagina, . Yu, T. V. Zemlyanukhina, N. E. Byramova et al., Synthesis of polymeric neoglycoconjugates based on N-substituted polyacrylamide, Glycoconj. J, vol.10, pp.142-151, 1993.

H. Coelho, T. Matsushita, G. Artigas, H. Hinou, F. J. Cañada et al., The quest for anticancer vaccines: deciphering the fine-epitope specificity of cancer-related monoclonal antibodies by combining microarray screening and saturation transfer difference NMR, J. Am. Chem. Soc, vol.137, pp.12438-12441, 2015.

C. Danussi, A. Coslovi, C. Campa, M. T. Mucignat, P. Spessotto et al., A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction, Glycobiology, vol.19, pp.1056-1067, 2009.

J. Dausset, J. Moullec, and J. Bernard, Acquired hemolytic anemia with polyagglutinability of red blood cells due to a new factor present in normal human serum (anti-Tn), Blood, vol.14, pp.1079-1093, 1959.

K. L. Dobrochaeva, N. R. Khasbiullina, N. V. Shilova, P. S. Obukhova, Y. A. Knirel et al., Human antibodies eluted from ligand-free Sepharose capable of binding bacterial polysaccharides and sulfated glycans, Mol. Immunol, vol.106, pp.63-68, 2019.

S. Dziadek, A. Hobel, E. Schmitt, and H. Kunz, A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response, Angew. Chem. Int. Ed, vol.44, pp.7630-7635, 2005.

A. Flechner, G. Butschak, A. Löffler, J. Rühmann, S. I. Nishimura et al., Cluster binding studies with two anti-Thomsen-Friedenreich (anti-core-1, CD176, TF) antibodies: evidence for a multiple TF epitope, Int. Immunopharmacol, vol.72, pp.186-194, 2019.

V. Friedenreich, The Thomsen Hemagglutination Phenomenon, 1930.

N. Gaidzik, A. Kaiser, D. Kowalczyk, U. Westerlind, B. Gerlitzki et al., Synthetic anti-tumor vaccines containing MUC1 glycopeptides with immunodominant domains -induction of a strong immune response against breast tumor tissues, Angew. Chem. Int. Ed, vol.50, pp.9977-9981, 2011.

N. Gaidzik, U. Westerlind, and H. Kunz, The development of synthetic antitumour vaccines from mucin glycopeptide antigens, Chem. Soc. Rev, vol.42, pp.4421-4442, 2013.

M. Huflejt, M. Vuskovic, D. Vasiliu, H. Xu, P. Obukhova et al., Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges, Mol. Immunol, vol.46, pp.3037-3049, 2009.

A. C. Kölbl, U. Jeschke, K. Friese, and U. Andergassen, The role of TF-and Tn-antigens in breast cancer metastasis, Histol. Histopathol, vol.31, issue.6, pp.613-621, 2016.

E. Y. Korchagina, T. V. Pochechueva, P. S. Obukhova, A. A. Formanovsky, A. Imberty et al., Design of the blood group AB glycotope, Glycoconj. J, vol.22, pp.127-133, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00305940

Q. Li, M. R. Anver, Z. Li, D. O. Butcher, and J. C. Gildersleeve, GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer, Int. J. Cancer, vol.126, issue.2, pp.459-468, 2010.

A. Matsumoto-takasaki, S. Hanashima, A. Aoki, N. Yuasa, H. Ogawa et al., Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters, J. Biochem, vol.151, issue.3, pp.273-282, 2012.

D. Mazurov, A. Ilinskaya, G. Heidecker, and A. Filatov, Role of O-Glycosylation and expression of CD43 and CD45 on the surfaces of effector T cells in human T cell leukemia virus type 1 cell-to-cell infection, J. Virol, vol.86, pp.2447-2458, 2012.

H. Nakada, Y. Numata, M. Inoue, N. Tanaka, H. Kitagawa et al., Elucidation of an essential structure recognized by an anti-GalNAc alpha-Ser(Thr) monoclonal antibody (MLS 128), J. Biol. Chem, vol.266, pp.12402-12405, 1991.

K. P. O'boyle, A. L. Markowitz, M. Khorshidi, P. Lalezari, B. M. Longenecker et al., Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-&6) T antigens, Hybridoma, vol.15, pp.401-408, 1996.

P. Obukhova, R. Rieben, and N. Bovin, Normal human serum contains high levels of anti-Gal?1-4GlcNAc antibodies, Xenotransplantation, vol.14, pp.627-635, 2007.

P. Obukhova, V. Piskarev, V. Severov, G. Pazynina, A. Tuzikov et al., Profiling of serum antibodies with printed glycan array: room for data misinterpretation, Glycoconj. J, vol.28, pp.501-505, 2011.

P. Obukhova, E. Korchagina, S. Henry, and N. Bovin, Natural anti-A and anti-B of the ABO system: allo-and autoantibodies have different epitope specificity, Transfusion, vol.52, issue.4, pp.860-869, 2012.

B. Palitzsch, S. Hartmann, N. Stregiou, M. Glaffig, E. Schmitt et al., A fully synthetic four-component antitumor vaccine consisting of a mucin glycopeptide antigen combined with three different T-helper-cell epitopes, Angew. Chem. Int. Ed, vol.53, pp.142457-142459, 2014.

S. Park, J. C. Gildersleeve, O. Blixt, and I. Shin, Carbohydrate microarrays, Chem. Soc. Rev, vol.42, issue.10, pp.4310-4326, 2013.

N. Persson, N. Stuhr-hansen, C. Risinger, S. Mereiter, A. Polónia et al., Epitope mapping of a new anti-Tn antibody detecting gastric cancer cells, Glycobiology, vol.27, issue.7, pp.635-645, 2017.

C. A. Reis, T. Sorensen, U. Mandel, L. David, E. Mirgorodskaya et al., Development and characterization of an antibody directed to an alpha-N-acetyl-D-galactosamine glycosylated MUC2 peptide, Glycoconj. J, vol.15, pp.51-62, 1998.

K. Sakai, N. Yuasa, K. Tsukamoto, A. Takasaki-matsumoto, Y. Yajima et al., Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments, J. Biochem, vol.147, pp.809-817, 2010.

E. Smorodin, O. A. Kurtenkov, B. L. Sergeyev, G. V. Pazynina, and N. V. Bovin, Specificity of human anti-carbohydrate IgG antibodies as probed with polyacrylamide-based glycoconjugates, Glycoconj. J, vol.20, pp.83-89, 2004.

E. P. Smorodin, O. A. Kurtenkov, B. L. Sergeyev, J. S. Branovets, J. G. Izotova et al., Specificity of serum anti-A(di) IgG antibodies from patients with gastrointestinal cancer, J. Immunoassay Immunochem, vol.32, issue.3, pp.170-190, 2011.

G. F. Springer, T and Tn, general carcinoma autoantigens, Science, vol.224, pp.1198-1206, 1984.

G. F. Springer, T and Tn pancarcinoma markers: autoantigenic adhesion molecules in pathogenesis, prebiopsy carcinoma-detection, and long-term breast carcinoma immunotherapy, Crit. Rev. Oncog, vol.6, pp.57-85, 1995.

G. F. Springer, Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy, J. Mol. Med, vol.75, pp.594-602, 1997.

G. F. Springer, C. R. Taylor, D. R. Howard, H. Tegtmeyer, P. R. Desai et al., Tn, a carcinoma-associated antigen, reacts with anti-Tn of normal human sera, Cancer, vol.55, issue.3, pp.561-569, 1985.

P. Volynsky, R. Efremov, I. Mikhalev, K. Dobrochaeva, A. Tuzikov et al., Why human anti-Gal?1-4Gal?1-4Glc natural antibodies do not recognize the trisaccharide on erythrocyte membrane? Molecular dynamics and immunochemical investigation, Mol. Immunol, vol.90, pp.87-97, 2017.

S. Von-gunten, D. F. Smith, R. D. Cummings, S. Riedel, S. Miescher et al., Intravenous immunoglobulin contains a broad repertoire of anticarbohydrate antibodies that is not restricted to the IgG2 subclass, J. Allergy Clin. Immunol, vol.123, issue.6, pp.1268-1276, 2009.

S. Von-mensdorff-pouilly, E. Petrakou, P. Kenemans, K. Van-uffelen, A. A. Verstraeten et al., Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and N-acetylgalactosamine (GalNAc) peptides, Int. J. Cancer, vol.86, pp.702-712, 2000.

C. Welinder, B. Baldetorp, C. Borrebaeck, B. M. Fredlund, and B. Jansson, A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti tumour activity, Glycobiology, vol.21, pp.1097-1107, 2011.

M. Zanetti, G. Lenert, and G. F. Springer, Idiotypes of pre-existing human anti-carcinoma anti-T and anti-Tn antibodies, Int. Immunol, vol.5, issue.2, pp.113-119, 1993.